Quick Answer
Organon & Co. reported Total Revenue of $6.22 billion for fiscal year 2025.
Organon & Co. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $6.22B | -2.9% |
| 2024 | $6.40B | +2.2% |
| 2023 | $6.26B | +1.4% |
| 2022 | $6.17B | -2.1% |
| 2021 | $6.30B | -3.5% |
| 2020 | $6.53B | -16.0% |
| 2019 | $7.78B | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.60B | +1.3% | +0.5% |
| June 30, 2025 | $1.59B | -0.8% | +5.4% |
| March 31, 2025 | $1.51B | -6.7% | -4.4% |
| September 30, 2024 | $1.58B | +4.1% | -1.6% |
| June 30, 2024 | $1.61B | -0.1% | -0.9% |
| March 31, 2024 | $1.62B | +5.5% | +6.8% |
| September 30, 2023 | $1.52B | -1.2% | -5.5% |
| June 30, 2023 | $1.61B | +1.5% | +4.6% |
- Organon & Co. showed a decrease of -2.9% in Total Revenue compared to the prior fiscal year.
- Over the 2019–2025 period, Organon & Co.’s total revenue has declined by 20.1% (from $7.78 billion to $6.22 billion).
- The most recent figure is from Organon & Co.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: